Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BT-001 |
Trade Name | |
Synonyms | BT 001|BT001 |
Drug Descriptions |
BT-001 is an engineered oncolytic vaccinia virus expressing GM-CSF and anti-CTLA4 antibody, which may trigger enhanced anti-tumor immune response (Cancer Res 2020;80(16 Suppl):Abstract nr 5602). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179623 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BT-001 | BT-001 | 0 | 1 |
BT-001 + Pembrolizumab | BT-001 Pembrolizumab | 0 | 1 |